Chinese pharmaceuticals firm's $40m US innovation investment

China-based Gloria Pharmaceuticals is investing $40m in the H round of financing for US digital medicine company Proteus Digital Health. Gloria hopes to benefit from technological innovation and boost its capacity to treat the growing number of Chinese suffering from chronic diseases such as hypertension, diabetes and mental illness. 

All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.